JADE BIOSCIENCES INC (JBIO) Stock Ownership
NASDAQ:JBIO • US0080642061
Current stock price
13.26 USD
-0.13 (-0.97%)
At close:
13.26 USD
0 (0%)
After Hours:
JBIO Ownership information
| Shares Outstanding | 49.32M |
| Float | 48.11M |
| Float Short Interest Percentage | 3.19% |
| Owners (insider) | 1.36% |
| Owners (institutional) | 100.86% |
| Owners (insider) change | 29.77% |
| Owners (institutional) change | 43.86% |
| Date | Name | Type | Shares | Price | Amount |
|---|---|---|---|---|---|
| Feb 12, 2026 | King Andrew James | Grant | 41250 | 0.00 | $ 0.00 |
| Feb 12, 2026 | Dahms Bradford D. | Grant | 37813 | 0.00 | $ 0.00 |
| Feb 12, 2026 | Bekiroglu Elizabeth | Grant | 28125 | 0.00 | $ 0.00 |
| Feb 12, 2026 | Frohlich Tom | Grant | 78750 | 0.00 | $ 0.00 |
| Oct 6, 2025 | Fairmount Funds Management LLC | Grant | 1333126 | 9.14 | $ 12,184,771.64 |
| Oct 6, 2025 | Fairmount Healthcare Fund II L.P. | Grant | 1333126 | 9.14 | $ 12,184,771.64 |
| Oct 6, 2025 | Fairmount Healthcare Co-Invest IV L.P. | Grant | 1333126 | 9.14 | $ 12,184,771.64 |
| Oct 6, 2025 | Kiselak Tomas | Grant | 1333126 | 9.14 | $ 12,184,771.64 |
| Oct 6, 2025 | Harwin Peter Evan | Grant | 1333126 | 9.14 | $ 12,184,771.64 |
| May 16, 2025 | Frohlich Tom | Open Market Purchase | 6000 | 7.40 | $ 44,400.00 |
| Apr 28, 2025 | RA CAPITAL MANAGEMENT, LLC | Other Aquisition | 1062326 | $ 0.00 | |
| Apr 28, 2025 | RA Capital Healthcare Fund LP | Other Aquisition | 1062326 | $ 0.00 | |
| Apr 28, 2025 | Kolchinsky Peter | Other Aquisition | 1062326 | $ 0.00 | |
| Apr 28, 2025 | Shah Rajeev M. | Other Aquisition | 1062326 | $ 0.00 |